Publications

The Impact of Archived HIV-1 Drug Resistance on Maintenance of Virologic Suppression Through Week 48 in Children Aged 2 to <15 Years Receiving DTG/3TC: PENTA-21 Intensive Pharmacokinetic Sub-Study

2026

Authors: Wang R, Chen W, Kumar A, Chan MK, Gupta A, Boles J, Botha JC, Byott M, Spyer MJ, Grant P, Gärtner K, Kamrunnahar K, Archary M, Violari A, Variava E, Cressey TR, Ahimbisibwe G, Kekitiinwa AR, Kityo C, Epalza C, Giaquinto C, Ford D, Turkova A, Buchanan AM, Nastouli E

Presented at: International AIDS Conference

PregInPoxVac maternal protocol: a phase 3 trial evaluating maternal immunogenicity and safety of the MVA-BN vaccine in the Democratic Republic of the Congo

2026

Authors: Morales Ruiz P, Milolo Tshilumba S, Maertens K, Maketa V, Kimbulu P, Mitashi F, Abu Azoum M, Kasereka G, Bisumba A, Salloum M, Bikoli-Bolombo F, Le Prevost M, Lemey G, Makenga G, Van Damme P, Van Geertruyden JP, Muhindo-Mavoko H, Mitashi P, Zola Matuvanga T, Larivière Y.

Published in: BMJ Open

Simulation-Based Predictions to Support the Development of a Pediatric Fixed-Dose Combination of Dolutegravir/Emtricitabine/Tenofovir Alafenamide Fumarate

2026

Authors: Waalewijn H, Bevers LAH, Lewis LL, Louey MD, Kawakatsu S, Zheng Y, Giaquinto C, Nardone A, Burger DM, ter Heine R, Colbers A, Svensson EM.

Published in: Clinical Pharmacokinetics

Barriers and facilitators to adherence of infants living with HIV in sub-Saharan Africa in an era of wide access to ART: a mixed-methods study

2026

Authors: Peay HL, Kruger S, Otwombe K, Boene H, Lain MG, Ngwenya N, Domínguez-Rodríguez S, Barnabas SL, Bingaman A, Kunene M, Giaquinto C, Henderson GE, Madiehe F, Maiga AI, Nhampossa T, Nkosi K, Rojo P, Rossi P, Torres N, Vaz P, Tagarro A; on behalf of the EPIICAL Consortium.

Published in: AIDS and Behavior

High Early Post-Discharge Mortality and Readmission in Children Living with HIV in Sub-Saharan Africa: 30-Day Outcomes from the SUPPORT Project

2026

Authors: Kyobe S, Amorim M, Kaudha E, Sukwa N, Mwiinga C, Mumbiro V, Ngouanom MPK, Abdulkarim S, Kane A, Sumbana J, Hamusonde K, Cambaco O, Matonse C, Gilbert A, Tembo J, Jacobs T, Gachet A, Fernández-Luis S, Madrid L, Ballesteros A, Gastesi I, Faye PM, Mavenyengwa R, Bates M, Tagarro A, Domínguez S, Chabala C, Mujuru HA, Sacarlal J, Buck C, Musiime V, Rojo P, Moraleda C

Presented at: International Workshop on Pediatrics and HIV

High prevalence of ESBL-producing bacteria isolated from rectal swabs of children living with HIV at the time of hospital discharge

2026

Authors: Sumbana J, Amorim M, Kyobe S, Mwiinga C, Ngouanom MPK, Kaudha E, Sukwa N, Mumbiro V, Kane A, Gilbert A, Tembo J, Bates M, Ballesteros A, Chabala C, Mujuru HA, Sacarlal J, Buck WC, Musiime V, Rojo P, Moraleda C

Presented at: International Workshop on Pediatrics and HIV

“Will she get better or worse at home?” A qualitative study on caregivers’ and healthcare providers’ perspectives on post-discharge mortality risk in paediatric HIV care in Mozambique

2026

Authors: Cambaco O, Amorim Moraleda M, Buck WC, Capurchande R, Ballesteros A, Kyobe S, Sacarlal J, Maixenchs M, Matonse C, Timbe E, Sumbana J, Rojo P, Cinta M, Buck WC, Capurchande R, Maixenchs M

Presented at: International Workshop on Pediatrics and HIV

Retrospective evaluation of school-related measures on pre-vaccination transmission dynamics of SARS-CoV-2

2026

Authors: Canfora B, Escosio RA, van Dorp CH, Boldea O, Bonten M, Nunes A, Rozhnova G.

Published in: Nature Communications Medicine

Cross-network, multicentre cohort study assessing real-world pregnancy and birth outcomes following prenatal dolutegravir exposure in Europe

2026

Authors: Sconza R, Vannappagari V, Kowalska JD, Thorne C; DOLOMITE-EPPICC Study Group; DOLOMITE-NEAT ID Study Group.

Presented at: AIDS 2026

Every-8-weeks injectable cabotegravir and rilpivirine is superior to daily oral tenofovir disoproxil fumarate/ lamivudine/ dolutegravir in adolescents living with HIV in sub-Saharan Africa: LATA 96-week results

2026

Authors: Bwakura Dangarembizi M, Chappell E, Kekitiinwa AR, Kityo C, Siika A, Archary M, Jafta L, Mujuru HA, Anena LD, Nakabuye S, Kiilu C, Mngqibisa R, Akabwai G, Mugerwa H, Walker S, Seeley J, Burger D, Omar A, Bamford A, South A, Nguyen H, Giaquinto C, Spittle B, Ford D, Pett S; LATA Trial Team.

Presented at: AIDS 2026

Sustained undetectable intact reservoir in early treated infants in Africa

2026

Authors: Reddy K, Cotugno N, Morrocchi E, Molechan C, Dominguez-Rodriguez S, Loubser S, Tiemessen CT, Barnabas S, Grazia Lain M, Otwombe K, Maiga A, Behuhuma O, Rojo P, Giaquinto C, Rossi P, Palma P, Ndung’u T, Tagarro A

Presented at: AIDS 2026

Sustaining advanced HIV disease care: Lessons from program integration and country experiences

2026

THRIVE Satellite Session at AIDS 2026

Organizers: Clinton Health Access Initiative, Unitaid

View presentation slides

Knowledge, Training, and Implementation Gaps in Delivery of the STOP AIDS Package for Pediatric Advanced HIV Disease: A Multi-Country Assessment

2026

Authors: Fernández-Luis S, de la Fuente L, Tusell M, Hergeth J, Prendergast AJ, Sacarlal J, Buck WC, Namusoke Magongo E, McEneaney P, Collins IJ, Schindele A, Evans C, Chingombe I, Mulowoza C, Moraleda C, Matsinhe M, Mushavi A, Frigati L, Rabie H, Levin L, Nzano B, Amamilo I, Brophy J, Nabitaka V, Maparo T, Bwakura M, Oladokun R, Mburu C, Choola T, Sekadde MP, Haule BT, Wambui J, Conroy J, Rojo P.

Presented at: International Workshop on Pediatrics and HIV

Demographic, laboratory and clinical characteristics and outcomes of seriously ill hospitalized Mozambican children with advanced HIV disease

2026

Authors: Mavume C, Fernández-Luis S, Schindele A, Salimo A, Cassam Y, Joaquim W, Maieca A, Beca L, Macassa E, Aguacheiro S, Liasse N, Martins L, Machava S, Ballesteros Á, Tusell M, de la Fuente Soro L, Gastesi I, Dominguez S, Moraleda C, Matsinhe M, Sacarlal J, Rojo P, Buck WC.

Presented at: International Workshop on Pediatrics and HIV

Uncovering the gaps: a mixed methods exploration of barriers to STOP-AIDS implementation

2026

Authors: Chingombe I, Mangwende M, Mapfumo HF, Madhuyu L, Ndlovu N, Chidhanguro D, Tavengwa N, Fernández-Luis S, Tusell M, Langhaug L, Muchekeza M, Nyachowe C, Chikunya J, Mushavi A, Prendergast A, Evans C.

Presented at: International Workshop on Pediatrics and HIV

Addressing gaps in provider-initiated testing and counseling and early infant diagnosis to optimize inpatient pediatric advanced HIV disease care in Mozambican hospitals

2026

Authors: Salimo A, Buck WC, Schindele A, Fernández-Luis S, Gastesi I, Mavume C, Cassam Y, Joaquim W, Maieca A, Beca L, Macassa E, Aguacheiro S, Liasse N, Martins L, Machava S, Ballesteros Á, Dominguez-Rodriguez S, Tusell M, de la Fuente Soro L, Matsinhe M, Moraleda C, Sacarlal J, Rojo P.

Presented at: International Workshop on Pediatrics and HIV

Implementation of the advanced HIV disease care package for hospitalized children: baseline results from a Quality Improvement initiative in Mozambique

2026

Authors: Cassam Y, Schindele A, Fernández-Luis S, Gastesi I, Salimo A, Joaquim W, Maieca A, Beca L, Mavume C, Macassa E, Aguacheiro S, Liasse N, Martins L, Machava S, Ballesteros Á, Tusell M, de la Fuente Soro L, Dominguez-Rodriguez S, Moraleda C, Matsinhe M, Sacarlal J, Rojo P, Buck WC.

Presented at: International Workshop on Pediatrics and HIV

Prevalence of Advanced HIV Disease (AHD) and missed screening opportunities among Children and Adolescents living with HIV (CALHIV) in Uganda

2026

Authors: Mulowoza C, Crichton S, Le Prevost M, Kalibbala D, Fernandez-Luis S, Fuente-Soro L, Kayaga J, Nyamaizi P, Kiweewa F, Collins IJ, Magongo EN.

Presented at: International Workshop on Pediatrics and HIV

“Will she get better or worse at home?” A qualitative study on caregivers’ and healthcare providers’ perspectives on post-discharge mortality risk in paediatric HIV care in Mozambique

2026

Authors: Cambaco O, Amorim M, Moraleda C, Buck WC, Capurchande R, Ballesteros Á, Kyobe S, Sacarlal J, Maixenchs M, Matonse C, Timbe E, Sumbana J, Rojo P, Moraleda C, Buck WC, Capurchande R, Ballesteros Á, Kyobe S, Sacarlal J, Maixenchs M

Presented at: International Workshop on Pediatrics and HIV

The impact of school-based mitigation measures on the transmission of respiratory pathogens: the case of SARS-CoV-2

2026

Authors: Fumanelli L, Guzzetta G, del Manso M, Bella A, Vicentini M, Djuric O, Bisaccia E, Mancuso P, Cilloni S, Larosa E, Pezzotti P, Giorgi Rossi P, Merler S.

Published in: International Journal of Epidemiology

Mobility data resolution needed to inform predictive models of spatial epidemic spread from mobile phone data

2026

Authors: Pullano G, Bansal S, Rubrichi S, Colizza V.

Published in: PLOS Computational Biology

Mpox clinical outcomes among people living with HIV and PrEP users: Findings from the MASH-1 multicentre cohort study

2026

Authors: Girometti N, Hill A, Simmons B, Byrne R, Blanco JL, Estrada V, Ghosn J, Curran A, Kowalska J, Sobande T, Martinez E; on behalf of the MASH-1 Study Group.

Published in: HIV Medicine (open access article available here)

T-cell subsets, T-cell receptor repertoire and HIV-1 virological reservoir in children initiating first-line dolutegravir versus standard-of-care ART: results from the ODYSSEY trial

2026

Authors: Gärtner K, Wyncoll J, Hammer ASB, Rattenborg MN, Adams S, Byott M, Alber D, Botha JC, Kekitiinwa AR, Kityo C, Bamford A, Bwakura-Dangarembizi M, Violari A, Ounchanum P, Lugemwa A, Rojo P, Giaquinto C, Gibb D, Ford D, Turkova A, Sandgaard KS, Nastouli E; ODYSSEY trial team.

Presented at: International Workshop on Pediatrics and HIV

HIV-1 resistance in children aged 2 to <15 years receiving DTG/3TC or DTG+2NRTI: results from the D3/PENTA-21 trial over 96 weeks

2026

Authors: Botha JC, Byott M, Chen W, Grant P, Spyer MJ, Wang R, Boles J, Gärtner K, Kamrunnahar K, Archary M, Violari A, Variava E, Cressey T, Ahimbisibwe G, Kekitiinwa A, Kityo C, Epalza C, Giaquinto C, Buchanan A, Ford D, Chan MK, Turkova A, Nastouli E, for the D3/PENTA21 trial team.

Presented at: International Workshop on Pediatrics and HIV

Predictors of viral non-suppression in children living with HIV initiating second-line antiretroviral therapy in the ODYSSEY and CHAPAS-4 trials

2026

Authors: Amuge P, Wyncoll J, Mujuru HA, Kekitiinwa AR, Lugemwa A, Kityo CM, Chabala C, Nyathi M, Nduna B, Musoke P, Srirompotong U, Violari A, Archary M, Cotton M, Mulenga V, Bwakura-Dangarembizi M, Elyanu PJ, Yawe I, Kaudha E, Musoro G, Ankunda R, Ndebele W, Mwamabazi M, Doerholt K, Giaquinto C, Rojo P, Gibb D, Bamford A, Musiime V, Turkova A, Ford D; on behalf of the ODYSSEY trial and CHAPAS-4 trial teams.

Presented at: International Workshop on Pediatrics and HIV

Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial

2026

Authors: Bielicki JA, Clements M, Musiime V, Moore DP, Sidat M, Mulenga V, Mutata C, Nalwanga D, Waggie Z, Chilundo J, Chabala C, Bwakura-Dangarembizi M, Archary M, Kiggwe A, Dangor Z, Spittle B, Kapasa M, Tagoola A, Jeki C, Sacarlal J, Buck WC, Chanda S, Mujuru HA, Giaquinto C, Madhi SA, Walker AS, Sharland M; on behalf of the PediCAP trial team

Published in: The Lancet

Empirical treatment with valganciclovir in infants living with HIV and hospitalised with severe pneumonia in Africa: a multicentre, open-label, factorial, randomised, controlled, superiority trial

2026

Authors: Moraleda C, Tagarro A, Domínguez-Rodríguez S, Musiime V, Mujuru H, Chabala C, Mvalo T, Iroh-Tam PY, Bramugy J, Madrid L, Sacarlal J, Passanduca A, Sidat M, Cassia U, Aanyu HT, Tagoola A, Mutata C, Nduna B, Chawinga C, Ghambi L, Bates M, Fernández-Luis S, Seni A, Gafur M, Nalwanga D, Nansera D, Bwakura-Dangarembizi M, Namuziya N, Egbe FN, Tembo J, Ballesteros Á, Moh R, Manukyan L, Lora D, Marcy O, Jacobs TG, Burger D, Bassat Q, Leroy V, Nardone A, Buck WC, Rojo P; on behalf of the Empirical Clinical Trial Group.

Published in: The Lancet

Performance of five risk stratification tools for paediatric pneumonia against WHO scores using data from the PediCAP trial in sub-Saharan Africa

2026

Authors: Nalwanga D, Clements M, Musiime V, Mulenga V, Mujuru AH, Sidat M, Buck WC, Madhi AS, Bielicki AJ, Moore PD, Walker S, Sharland M PediCAP trial team

Published in: medRxiv (Preprint)

Representations of mpox in UK news media during the 2022 outbreak: a qualitative analysis

2026

Authors: Le Prevost M, Nicholls EJ, Bilardi D, David A, Kandasamy S, Stizioli M, Denford S, May T, Tan E, Tariq S.

Published in: BMC Public Health

Evaluating Mucosal and Systemic Immunity in an Observational Cohort of South African Children Hospitalised with Acute Respiratory Tract Infections

2026

Authors: van Weelden G, Rabie H, Redfern A, Al Barday M, Dewandel I, Trutter C, van Niekerk M, Mentor M, Mfazwe A, van der Gaast de Jongh CE, Dunbar R, Bosch C, Buddingh EP, Lugthart G, et al.

Published in: International Journal of Infectious Diseases

Symptomatology of SARS-CoV-2 versus seasonal coronavirus infection in healthy young children

2026

Authors: Junquera Guinovart L, Hauser-van Westrhenen SEM, Schuurman R, Bruijning-Verhagen PCJL.

Published in: Journal of Infection

Counterfactual evaluation of elementary and secondary school policies in the COVID-19 pandemic

2026

Authors: Canfora B, Escosio RA, Boldea O, Nunes A, Rozhnova G.

Published in: Nature Communications

PIPELINE – Pregnancy and Infant Preparedness Platform in Europe

2026

Presented by: Turkova A, on behalf of the PIPELINE team

Presented at: ESPID 2026

Improving Evidence Based Management of Paediatric Infectious Diseases: Role of Trials and Networks

2026

Presented by: Di Gibb

Presented at: ESPID 2026

Remdesivir in hospitalised children less than 2 years old with RSV-associated lower respiratory tract infections: a Phase 2 randomised controlled trial (THAI-CARES RSV)

2026

Authors: Sudjaritruk T, Salvadori N, Gijón M, Srirompotong U, Sachdev S, Kamolrattana R, Papakhee S, Ruenglerdpong S, Chantasrisawad N, Rattanawijit M, Sukrakanchana P, Than-in-at K, Ngo-Giang-Huong N, Dominguez S, Giaquinto C, Lallemant M, Rojo P, Cressey TR; THAI-CARES RSV Study Team.

Presented at: ESPID 2026

Online training as a tool to foster behaviour change and capacity building in infection prevention and control, and antimicrobial stewardship (the Team-COACH project)

2026

Authors: Goycochea Valdivia WA, Gachet A, Amores M, Kopsidas I, Brigadoi G, Barbieri E, Bason M, Kousi D, Aboza García M, Villaverde S, Dona D, Tsopela G-C, Neth O, Arias A, Cantarutti L, Giaquinto C, Gastesi I, Rojo P, Epalza Ibarrondo C and the TEAM-COACH working group

Presented at: ESPID 2026

Strong engagement and positive satisfaction among outpatient healthcare workers in an online infection prevention and antimicrobial stewardship program

2026

Authors: Barbieri E, Villaverde S, Aboza García M, Kopsidas I, Bason M, Brigadoi G, Arias A, Goycochea Valdivia WA, Kousi D, Dona D, Neth O, Tsopela G-C, Cantarutti L, Giaquinto C, Gachet A, Gastesi I, Amores M, Rojo P, Epalza Ibarrondo C; TEAM-COACH Group

Presented at: ESPID 2026

Multi-country digital IPC and AMS training in paediatric inpatient settings: implementation results and outcomes from Team-COACH

2026

Authors: Kousi D, Goycochea Valdivia WA, Brigadoi G, Villaverde S, Barbieri E, Bason M, Tsopela G-C, Aboza García M, Dona D, Kopsidas I, Neth O, Arias A, Cantarutti L, Giaquinto C, Gachet A, Gastesi I, Amores M, Rojo P, Epalza Ibarrondo C

Presented at: ESPID 2026

High engagement and positive satisfaction of healthcare workers about an online training for infection prevention and control and antimicrobial stewardship (the Team-COACH project)

2026

Authors: Villaverde S, Brigadoi G, Goycochea Valdivia WA, Kopsidas J, Barbieri E, Bason M, Kousi D, Arias A, Aboza García M, Tsopela G-C, Dona D, Neth O, Cantarutti L, Giaquinto C, Gachet A, Gastesi I, Amores M, Rojo P, Epalza Ibarrondo C and the TEAM-COACH working group

Presented at: ESPID 2026

Assessment of pediatric clinical practice indicators in infection prevention and control and antimicrobial stewardship before and after involvement in an online educational programme (Team-COACH project)

2026

Authors: Brigadoi G, Villaverde S, Kousi D, Goycochea Valdivia WA, Barbieri E, Bason M, Arias A, Dona D, Tsopela G-C, Aboza García M, Kopsidas I, Neth O, Cantarutti L, Giaquinto C, Amores M, Gachet A, Gastesi I, Rojo P, Epalza Ibarrondo C; The Team-COACH Working Group

Presented at: ESPID 2026

Barriers to paediatric and neonatal Candida management: a global survey on implementing international guidelines

2026

Authors: Ferreras-Antolin L, McMullan B, Santolaya ME, Carlesse F, Groll AH, Kopsidas J, Oletto A, Dramowski A, Warris A; Penta Serious Bacterial and Fungal Infections Working Group

Presented at: ESPID 2026

Preferences for RSV prevention strategies among parents and healthcare professionals in five European countries

2026

Authors: Paranthoen L , Hendrickx G , Maertens K  on behalf of the PIPELINE Consortium

Presented at: ESPID 2026

Neonatal-specific infection prevention and control practices in NICUs across the WHO European region: results of the NeoIPC-UENPS survey

2026

Authors: Minotti C, Cantini MS, Sanchez C, Vertecchi G, Moretti C, Giaquinto C, Bielicki J, on behalf of the NeolPC Consortium.

Presented at: ESPID 2026

Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial

2026

Authors: Mujuru HA, White E, Kekitiinwa AR, Lugemwa A, Kityo C, Violari A, Ahimbisibwe GM, Variava E, Archary M, Cotton M, Ounchanum P, Puthanakit T, Kanjanavanit S, Ngampiyaskul C, Kobbe R, Bandi S, Epaiza C, Bwakura-Dangarembizi M, Bbuye D, Kasozi M, Kaudha E, Cressey TR, Giaquinto C, Jafta L, Bamford A, Rojo P, Gibb DM, Turkova A, Ford D, on behalf of the ODYSSEY Trial Team

Published in: Open Forum Infectious Diseases

Impact of co-amoxiclav versus amoxicillin on the gastrointestinal microbiota in sub-Saharan children hospitalized with pneumonia

2026

Authors: Rodriguez-Ruiz JP, Hiel S, Musiime V, Mulenga V, Mujuru HA, Madhi SA, Moore DP, Archary M, Clements M, Walker AS, Bielicki JA, Sharland M, Malhotra-Kumar S.

Published In: npj Antimicrobials and Resistance

Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancy

2026

Authors: van der Wekken-Pas L, Hidalgo-Tenorio C, Rockstroh JK, van Bremen K, Richel O, Molto J, Lambert JS, de Kanter C, Konopnicki D, Burger D, Colbers A.

Published in: Journal of Antimicrobial Chemotherapy

Dolutegravir as first- or second-line treatment for children living with HIV: 240-week follow-up of the ODYSSEY randomised trial

2026

Authors: Mujuru HA, White E, Kekitiinwa AR, Lugemwa A, Kityo C, Violari A, Ahimbisibwe GM, Variava E, Archary M, Cotton M, Ounchanum P, Puthanakit T, Kanjanavanit S, Ngampiyaskul C, Kobbe R, Bandi S, Epaiza C, Bwakura-Dangarembizi M, Bbuye D, Kasozi M, Kaudha E, Cressey TR, Giaquinto C, Jafta L, Bamford A, Rojo P, Gibb DM, Turkova A, Ford D, on behalf of the ODYSSEY Trial Team

Published inOpen Forum Infectious Diseases

Mpox in Children and Adolescents

2026

Authors: Aguilera-Alonso D, Sam-Agudu NA, Muhindo-Mavoko H, Pana ZD.

Published in: The Pediatric Infectious Disease Journal

Kangaroo Care as an intervention in randomised controlled trials in neonatal intensive care

2026

Authors: Minotti C, Wallis L, Hoesli J, Schlaeppi C, Nyantakyi E, Schultes MT, Jost K, Bielicki JA.

Published in: Pediatric Research

Risk factors for antibiotic-resistant bacterial colonisation in European Neonatal Units

2026

Authors: Cook A, Berkell M, van Werkhoven H, Sieswerda E, Smith DRM, Minotti C, van Heirstraeten L, Malhotra-Kumar S, Bielicki JA; on behalf of the NeoIPC Consortium

Presented at: Pediatric Academic Societies (PAS) Meeting

123456789101112131415161718